1 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
2 Department of Medicine, Northwell Health, Manhasset, New York.
J Adolesc Young Adult Oncol. 2019 Jun;8(3):236-242. doi: 10.1089/jayao.2018.0143. Epub 2019 Feb 28.
The increase in cost-sharing between patients and payers has resulted in financial toxicity in cancer patients, particularly among young adult (YA) patients and survivors (<40 years of age). This study explored financial toxicity and its impact on psychological well-being, self-efficacy for coping with cancer, and cost-coping behaviors among a sample of YA cancer patients and survivors. One hundred forty YAs completed an anonymous online survey. The Comprehensive Score for Financial Toxicity measured financial toxicity and the Cancer Behavior Inventory-Brief measured coping self-efficacy. The Patient Health Questionnaire-4 and items from the Impact of Cancer-Young Adult and the Cancer Needs Questionnaire-Young People assessed psychological well-being. A single item assessed cost-coping behaviors (i.e., skipping or delaying treatment because of its cost). Analyses included Pearson and Spearman correlation matrices and multivariate regression modeling. Worse financial toxicity was associated with lower insurance satisfaction ( = 0.52, < 0.001), higher levels of depressive and anxiety symptoms ( = -0.42, < 0.001), greater worry ( < 0.001), and lower self-efficacy in coping with cancer (i.e., maintaining independence and a positive attitude, = 0.41, < 0.001; coping and stress management, = 0.43, < 0.001; and managing negative effect, = 0.20, = 0.02). In multivariate modeling, financial toxicity related to skipping or delaying treatment and greater anxiety and depression symptomology, controlling for relevant covariates. The findings suggest financial toxicity negatively impacts many facets of the YA cancer experience. There is a need to address the cost of cancer care with patients to ensure they are informed about the financial implications of treatment decisions and to support financial planning as needed.
患者和支付方之间的费用分担增加导致癌症患者出现财务毒性,尤其是在年轻成年(YA)患者和幸存者(<40 岁)中。本研究探索了财务毒性及其对年轻成年癌症患者和幸存者心理幸福感、应对癌症的自我效能以及成本应对行为的影响。140 名 YA 完成了一份匿名在线调查。综合财务毒性评分(Comprehensive Score for Financial Toxicity)衡量财务毒性,癌症行为量表-简短版(Cancer Behavior Inventory-Brief)衡量应对自我效能。患者健康问卷-4(Patient Health Questionnaire-4)和癌症对年轻成人的影响量表(Impact of Cancer-Young Adult)及癌症需求问卷-年轻人(Cancer Needs Questionnaire-Young People)的项目评估心理幸福感。一个项目评估了成本应对行为(即因费用而跳过或延迟治疗)。分析包括 Pearson 和 Spearman 相关矩阵以及多元回归建模。财务毒性越严重,保险满意度越低( = 0.52, < 0.001),抑郁和焦虑症状越严重( = -0.42, < 0.001),担忧程度越高( < 0.001),应对癌症的自我效能越低(即保持独立和积极态度, = 0.41, < 0.001;应对和压力管理, = 0.43, < 0.001;和管理负面影响, = 0.20, = 0.02)。在多元建模中,财务毒性与跳过或延迟治疗以及更高的焦虑和抑郁症状相关,控制了相关协变量。研究结果表明,财务毒性对年轻成年癌症患者体验的许多方面都有负面影响。需要与患者一起解决癌症护理的费用问题,以确保他们了解治疗决策的财务影响,并在需要时支持财务规划。